Eisbach Bio GmbH
Eisbach Bio GmbH
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors | Advanced Solid Tumor; HRR Deficiency; Homologous Recombination Deficiency | Recruiting | Phase 1 / Phase 2 | 2024-09-19 | NCT06525298 |